David Sinclair· PhD
Resveratrol at 200 mg for 24 weeks showed an improvement of glycemic control by reducing insulin resistance with significant beneficial impact on chronic inflammation, oxidative stress 4/9
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Resveratrol at 200 mg for 24 weeks showed an improvement of glycemic control by reducing insulin resistance with significant beneficial impact on chronic inflammation, oxidative stress 4/9
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.